Wire · opportunities
Ambient AI Is Not Losing Your Trial Data. It's Quietly Deciding What Counts.
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 18 July 2026 · Fusion42 review
Ambient AI clinical scribes are systematically omitting contextual patient data—medication non-adherence triggers, social determinants, caregiver burden—that are essential for trial data integrity, creating a source documentation crisis that current FDA audit-trail frameworks do not catch.
This Wire brief sits within Fusion42's coverage of Digital Health.
◆ ◆ The Wire takeaway
If you're selling ambient AI scribes into clinical trials, you've built a system that passes FDA audit trails while systematically deleting the patient context that makes trial conclusions valid. Your vendor qualification buyer is about to discover their data is cleaner but worthless.
◆ Coverage
1 source · 18 Jul 2026
◆ Related on Wire
◆ Topics